Post-myocardial infarction secondary prevention — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Reduce beta-blocker therapy while maintaining other secondary prevention
Beyond one year after MI, beta-blocker continuation should be reassessed when LVEF is preserved and there is no other indication, particularly with symptomatic bradycardia. Ivabradine is not indicated, and statin and antiplatelet secondary prevention should not be withdrawn for this reason.
Reference: 2025 ACC/AHA Guideline for Acute Coronary Syndromes: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309